Our Board of Directors represent the diverse communities within the regenerative medicine movement. Clinic practitioners, researchers, patients, and regulators all share a common goal, but with different visions. Our leadership, including this and our other boards, reflect an example of the larger system working together to bring cohesiveness to these communities, based on our "interests" for patients, rather than our "positions."

Board Members

Theresa Taylor, Acting Director
Theresa Taylor, Acting Director

Taylored Treats

press to zoom
Doug Oliver, M.S.W.
Doug Oliver, M.S.W.

RegenConBio, LLC

press to zoom
Clay Graybeal, Ph.D., M.S.W.
Clay Graybeal, Ph.D., M.S.W.

University of New England

press to zoom
David B. Harrell, Ph.D.
David B. Harrell, Ph.D.

Harrell BioScience Consulting, LLC

press to zoom
Keith March, MD, Ph.D.
Keith March, MD, Ph.D.

University of Florida

press to zoom
Dimitry Shvartsman, Ph.D.
Dimitry Shvartsman, Ph.D.

Senior Research Manager Harvard Stem Cell Institute

press to zoom
Keith Uselton, CPA/APV
Keith Uselton, CPA/APV

Principal, Uselton, Clay & Bright

press to zoom
Samantha Wilkinson, BS
Samantha Wilkinson, BS

Patients For Stem Cells

press to zoom